Queen Esther' follows a Jewish orphan's journey from Vienna to Maine to Jerusalem, marking his first work to directly engage ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.

Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...

In arid West Texas, water seeps and bubbles from old wells, sometimes carrying oil, brackish water or other pollutants to the surface. But the real danger lies underground — where oil, salt, and toxic ...

In the face of the femicide crisis in Colombia, a second crisis persists: hundreds of children are left orphaned each year and without support from the state.